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Background: The majority of pandemic 2009 H1N1 (A(H1N1)pdm09) influenza virus (IV) caused mild symptoms in
most infected patients, however, a greater rate of severe disease was observed in healthy young adults and
children without co-morbid conditions. The purpose of this work was to study in ferrets the dynamics of infection
of two contemporary strains of human A(H1N1)pdm09 IV, one isolated from a patient showing mild disease and
the other one from a fatal case.
Methods: Viral strains isolated from a patient showing mild disease-M (A/CastillaLaMancha/RR5661/2009) or from a
fatal case-F (A/CastillaLaMancha/RR5911/2009), both without known comorbid conditions, were inoculated in two
groups of ferrets and clinical and pathological conditions were analysed.
Results: Mild to severe clinical symptoms were observed in animals from both groups. A clinical score distribution
was applied in which ferrets with mild clinical signs were distributed on a non-severe group (NS) and ferrets with
severe clinical signs on a severe group (S), regardless of the virus used in the infection. Animals on S showed a
significant decrease in body weight compared to animals on NS at 4 to 7 days post-infection (dpi). Clinical progress
correlated with histopathological findings. Concentrations of haptoglobin (Hp) and serum amyloid A (SAA) increased
on both groups after 2 dpi. Clinically severe infected ferrets showed a stronger antibody response and higher viral titres
after infection (p = 0.001).
Conclusions: The severity in the progress of infection was independent from the virus used for infection suggesting
that the host immune response was determinant in the outcome of the infection. The diversity observed in ferrets
mimicked the variability found in the human population.
Keywords: Pandemic A(H1N1)pdm09, Clinical response, FerretsIntroduction
Influenza A viruses are classified as members of the
family Orthomyxoviridae. They are classified according
their haemagglutinin (HA) and neuraminidase (NA)
molecules, which are the basis of the antigenicity [1].
They can produce significant respiratory disease in
humans and in a whole range of avian and mammals
species. In some occasions, simultaneous infection in a
susceptible species by more than one influenza A* Correspondence: maria.montoya@pirbright.ac.uk
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article, unless otherwise stated.viruses can lead to gene mixing, or reassortment. These
processes can originate a novel influenza virus strain,
against which human population would have few or no
existing immunity [2]. A new influenza A virus from H1N1
subtype, possessing high transmissibility but relatively low
virulence, emerged in 2009 (A(H1N1)pdm09) rapidly
spreading across the entire globe and causing the first
pandemic of the 21st century. It carried genes of avian,
swine and human IV [3,4]. Nowadays, A(H1N1)pdm09
still remain being an important issue of public health, and
in general terms, A(H1N1)pdm09 infection can cause mild
and self-limiting symptoms [5]. However, in some cases the
disease progresses towards severity, exhibiting symptomsed Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Martínez-Orellana et al. Virology Journal  (2015) 12:48 Page 2 of 10that have been characterized by severe or complicated
illness, often requiring hospitalization and mortality [6-8].
Previous studies in our group indicated that the virus
isolated from the fatal case replicates faster, induces
higher levels of cytokines in human alveolar lung epithe-
lial cells and is more pathogenic in a murine model
in vivo, compared with the virus obtained from the pa-
tient with mild disease [9]. Even though mice have been
widely used as animal model for influenza studies, it is
not a natural host for influenza virus infection. On the
other hand, ferrets (Mustela putorius furo), are well rec-
ognized as an animal model for IV. Together with their
similarities with humans in the respiratory tract, lung
physiology and airway morphology, ferrets also develop
clinical signs to influenza infections similar to humans,
usually restricted to the upper respiratory tract including
sneezing, nasal discharge, malaise, and pyrexia. In gen-
eral terms, ferrets develop mild clinical signs, and occa-
sionally pneumonia, which is more severe or even fatal
depending on the age of the host and/or the strain of
the virus [10-12]. On the other hand, as an outbreed ani-
mal, the response developed in ferrets when infected
with IV goes from mild clinical signs to severe or even a
fatal result, similar to the response found in patients.
This study was focused on the clinical response exhib-
ited on infected ferrets with the two viruses which
showed differential virulence in mice. Thus, a thorough
clinical scoring was established, enlarging the spectrum
of clinical signs usually analyzed [13]. Also, acute phase
proteins such as haptoglobin and serum amiloid albumin
were studied for the first time in IV infected ferrets. Our
results demonstrate that, contrary to the outcome in
mice, the severity in the progress of infection was inde-
pendent from the virus used for infection, indicating that
the host response was determinant in the outcome of
the infection.
Materials and methods
Ethics statement
All experiments were performed under a reviewed and
approved protocol (n° 1976) by “Comissió d’Ètica en
l’Experimentació Animal I Humana de la Universitat
Autònoma de Barcelona”. Ferrets were housed in groups
on experimental isolation rooms at the biosafety level 3
facilities of the Centre de Recerca en Sanitat Animal
(CReSA, Barcelona, Spain).
Virus and cells
Two distinct IV named A/CastillaLaMancha/RR5661/2009
(M) and A/CastillaLaMancha/RR5911/2009 (F), were
isolated at the National Influenza Centre (CNM, ISCIII)
from respiratory samples sent by the Spanish Influenza
Surveillance System for virological characterization. Virus
M was isolated from a 23 years old male patient whoshowed mild clinical signs of influenza, and virus F was
isolated from a 35 years old female patient who developed
an infection with fatal consequence. Neither of the pa-
tients presented previous pathology at the moment of
infection. Both viruses were thoroughly described in
Rodriguez et al. manuscript [9].
Madin-Darby Canine kidney (MDCK) cells were cul-
tured in Dulbecco's Modified Eagle Medium (DMEM) sup-
plemented with 5% fetal bovine serum (FBS), 100UI/ml
penicillin and 100ug/ml streptomycin, 2 mM glutamine.
IV M and F were grown in MDCK three times. M
virus had a titre of 108,3 TCID50/ml and F virus had a
titre of 108,2 TCID50/ml.
Animals and infection
Fourteen adult ferrets (Mustela putorius furo) under
24 month-old were numbered from 1 to 14, and were
randomly selected from a stable, purposely bred colony
(Isoquimen, Spain). Ferrets were randomly assigned to
different experimental groups. The groups were sepa-
rated into experimental isolation rooms, and kept for
one week in acclimation. Ferrets were kept in standard
housing cages and were provided with commercial
food pellets and tap water ad libitum throughout the
experiment. Animals were divided into three groups.
The control group (1) included two ferrets, number 1
(male) and number 2 (female) and they were inoculated
intratracheally with PBS. Group 2 included animals
infected with M strain numbered from 3 to 8 and was
integrated by 4 males (ferrets 3 to 6) and two females
(ferrets 7 and 8). Group 3 included animals infected
with F strain numbered from 9 to 14 and they were
all males. Ferrets were intratracheally inoculated with
200 μl containing 106 TCID50 of the corresponding
virus. All ferrets were proven seronegative at 0 dpi by
ID ScreenH Influenza A Antibody Competition ELISA
(ID VET, France).
Clinical score
Ferrets were monitored daily for clinical signs and changes
in temperature and body weight. Clinical signs were
recorded according to parameters defined in Table 1.
Changes in rectal temperature and body weight were
measured at approximately the same time each day. Any
animal losing 25% of its day 0 body weight, exhibiting a
scoring of more than 20 points or determined to be in a
moribund state was humanely euthanized.
Sampling
Samples of blood and serum were collected at 0, 2, 4, 7,
10 and 14 dpi. Two animals of groups 2 and 3 were
euthanized at 4, 7 and 14 dpi. From these animals
samples of lung, trachea and bronchoalveolar lavage
(BAL) were collected.
Table 1 Clinical Score
Clinical score 0 1 2 3
Playful normal mild apathy apathetic
Arched back normal arched
Bristly hair no bristly bristly tail bristly tail and back all body bristly
Sneezing no sporadic frecuent
Nasal secretion no secretion low abundant
Conjunctival secretion no secretion low abundant
Breathing rate normal (40–50) 50-70 70<
Auscultation normal anomalous
Lost weight no lost weight (1-5%) (5-10%) (>10)
Temperature normal (37.5-39,4) hyperthermia (39.5-40°C) (>40) <37
Mucous normal congestive
Heart rate <250 250-300 300 <
Animals were monitored daily at the same time for clinical observations.
Martínez-Orellana et al. Virology Journal  (2015) 12:48 Page 3 of 10All the ferrets were sedated with 0.5 mg/kg butorpha-
nol administered subcutaneously for blood collection.
2 ml of blood were taken from Cava Cranial Vein at 0,
2, 4, 7, 10 and 14 dpi. All samples were collected into a
1 ml blood-heparine tubes for Acute Phase Protein
(APP) determination. Heparin blood samples were cen-
trifugated at 3000 rpm for 10 minutes at 4°C to separate
plasma sample. Plasma samples were store in −20°C.
Acute phase proteins
Acute phase proteins were determined by commercial
ELISAs according to the manufacturer’s recommendation
(Haptoglobin Assay and Multispecies Serum Amyloid A
Immunoassay, both from Tridelta Development Ltd,
County Kildare, Ireland). Serum samples were tested in
duplicate.
Hemagglutination Inhibition (HI) Assay
Antibodies against IV were measured using a HI assay using
chicken red blood cells (RBC) and 4 hemagglutination units
of either M and F viruses. Before assay, sera were treated
overnight at 37°C with four volumes of Receptor Destroying
Enzyme (RDE) (Sigma-Aldrich SA, Madrid, Spain) solu-
tion (100 U/ml) to remove non-specific inhibitors of
hemagglutination. The following day, serum samples
were incubated for 30 min at 56°C after the addition of
five volumes 1.5% sodium citrate. Finally, one volume
of a 50% suspension of RBC was added and incubated
for 1 hour at 4°C. Known positive and negative sera were
used as controls. HI titres of >40 were considered positive.
Histopathology and Immunohistochemistry
A complete necropsy was performed on all animals imme-
diately after euthanasia. No major lesions were observed
macroscopically in any organ at necropsy. Lung samples
were taken in a standardized way, not guided by changesas seen in the gross pathology. Tissue samples were fixed
for 48 hours in neutral-buffered 10% formalin. They were
then embedded in paraffin wax, sectioned at 3 μm, and
stained with haematoxylin and eosin (HE) for histopatho-
logical assessment.
Influenza A virus antigen detection was performed in
tissues stained with a primary antibody against the influ-
enza A nucleoprotein (NP). Briefly, paraffin-embedded
samples were sectioned at 3 μm thick, dewaxed and
treated with 3% H2O2 in methanol to eliminate the en-
dogenous peroxidase. Then, sections were treated with
protease at 37°C for 10 minutes and blocked with 2%
bovine serum albumin (85040C, Sigma-Aldrich Quimica,
S.A., Spain) for one hour. Later, tissues were incubated
with the primary monoclonal antibody anti-NP Influenza
A virus (ATCC, HB-65, H16L-10-4R5) diluted 1:250, at
4°C overnight. After being rinsed, the samples were
incubated with biotinylated goat anti-mouse IgG secondary
antibody (Dako, immunoglobulins AS, Glostrup, Denmark),
followed by incubation with avidin-biotin-peroxidase com-
plex (ABC) (Thermo Fisher Scientific, Rockford, IL, USA).
The reaction was developed with 3,3'-Diaminobenzidine
tetrahydrochloride (DAB) (Sigma-Aldrich, Madrid, Spain)
at room temperature, followed by counterstaining with
Mayer's haematoxylin. Swine lung sections from pig
experimentally infected with Influenza A virus, were used
as positive controls. Same sections in which the specific
primary antibodies were substituted with PBS were used
as negative controls.
Viral load
Tissue samples of ferrets were collected and snap frozen
on dry ice and stored at −80°C until further processing.
Tissue samples were weighed and subsequently homoge-
nized and centrifuged briefly. Infectivity of M and F viruses
was determined by plaque assay in MDCK cells. MDCK
Table 2 Clinical score classification per animal
Inoculum Animal
number
Clinical score day 4
post-infection
Group
MOCK 1 4 CONTROL
2 4 CONTROL
A/CastillaLaMancha/
RR5661/2009(M)
3 6 NON SEVERE
4 19 SEVERE
5 13 SEVERE
6 17 SEVERE
7 13 SEVERE
8 11 NON SEVERE
A/CastillaLaMancha/
RR5911/2009(F)
9 14 SEVERE
10 11 NON SEVERE
11 11 NON SEVERE
12 10 NON SEVERE
13 6 NON SEVERE
14 11 NON SEVERE
Animals were classified according to each individual clinical score. Ferrets with
less than 4 points remained as control (C), ferrets scoring within 6 to 11 were
classified as non severe (NS) and animals scoring within 12 to 19 were
classified as severe (S).
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with 0.1 ml of 10-fold dilutions for each homogenized
tissues (101–106 PFU) diluted in Phosphate Buffer Saline
(PBS) (AttendBio Research, S.L, Barcelona, Spain) and 1%
bovine serum albumin (BSA) (Sigma-Aldrich SA, Madrid,
Spain) at room temperature. Samples were adsorbed to
MDCK cells for 1 hour, with shaking every 15 minutes.
After then, inoculums were aspirated and the cells were
washed once with PBS (Lonza, Walkesville, USA). Wells
were overlaid with 1.4% Noble agar (Becton Dickinson,
France) mixed 1:1 with Minimum Essential Medium Eagle
(MEM) (Sigma-Aldrich SA, Madrid, Spain) supplemented
with 100UI/ml penicillin and 100ug/ml streptomycin
(Invitrogen ®, Barcelona, Spain) and 0.5 μg/ml of bovine
trypsin (Sigma-Aldrich SA, Madrid, Spain). Plates were
inverted and incubated for 4 days. Cells were fixed for
20 min using 10% formalin (Sigma-Aldrich SA, Madrid,
Spain) and then overlaid with 1% crystal violet (Anorsa,
Barcelona, Spain). Cells were then washed with water to
visualized plaques. Plaques were counted and compared
to uninfected cells.
Statistical analysis
All statistical analysis was performed using SPSS 15.0
software (SPSS Inc., Chicago, IL, USA). For all analyses,
ferret was used as the experimental unit. The signifi-
cance level (α) was set at 0.05 with statistical tendencies
reported when P < 0.10. The Shapiro Wilk’s and the
Levene test were used to evaluate the normality of the
distribution of the examined quantitative variables, and
the homogeneity of variances, respectively. It was not
detected any continuous variable that had a normal dis-
tribution. Thus, a non-parametric test (Wilcoxon test)
using the U Mann–Whitney test to compare each pair of
values was used to compare the different values obtained
for all the parameters (clinical, score, acute phase proteins,
antibody response and viral load), between groups
(NS and S) at all sampling times.
Results
Clinical score
During the course of the experiment, clinical observa-
tions scores were recorded daily according to the score
set in Table 1. Infected ferrets started to show clinical
signs such as decrease in activity level, nasal discharge
and/or sneezing at 2 dpi which extended over the fol-
lowing 10 days in both infected groups. As an outbreed
animals, ferrets from both infected groups showed high
variability in the progress of the clinical infection. In
order to analyse each individual ferret, animals were
classified according to each clinical score: uninfected
control (C) ferrets obtained less than 4 points, ferrets
scoring within 6 to 11 were classified as non severe (NS)
and animals scoring within 12 to 19 were classified assevere (S). Regardless of the virus used as inoculum, ani-
mal distribution was established as follow: control group
(C) included two ferrets, non-severe group (NS) included
seven ferrets, numbers 3, 10, 11, 12, 13, 14 (males) and
8 (female) and severe group (S) included five ferrets,
numbers 4, 5, 6, 9 (males) and 7 (female) (Table 2).
The proportion of severe and non severe affected ani-
mal did not correlate with the virus used for infection.
Animals belonging to the S group paradoxically included
most of the M infected animals: 4 animals were infected
with M-virus whereas 1 animal was infected with F-virus.
NS group included 5 animals infected with F-virus and 2
animals infected with M-virus.
At 4 dpi, one ferret infected with M virus and one fer-
ret infected with F virus lost around 25% of body weight
and scored more than 20 points. Both animals were hu-
manely euthanized. Clinical conditions were significantly
affected on infected-ferrets throughout infection. Ani-
mals belonging to NS showed a statistically significant
clinical score when compared with control animals at 2,
3 and 4 dpi (p < 0.05) (Figure 1A). A statistical tendency
(p < 0.10) in higher clinical score was observed in S ani-
mals when compared with control group at 2, 3 and 4
dpi. On the following days: 5, 6 and 7 dpi, a tendency
persisted within animals from NS when compared with
control ferrets (Figure 1A). The group with severe
clinical signs had a significant decrease in body weight
(p < 0.05) when compared to NS at 2 dpi. At 4 dpi,
there was a tendency (p < 0.10) reflected in higher
Figure 1 Clinical signs of disease in ferrets following infection with M or F viruses. Animals were monitored daily for clinical observations
using a specific scoring system from Table 1. (A) Clinical score changes exhibited by S and NS group showing a statistically significant severe
clinical score when compared with C animals at day 2, 3 and 4 post-infection (p < 0.05) (B) Percentage of weight loss on S and NS ferrets
showing a significant decrease when compared with C group at day 4 post-infection. (C) Body temperature from animals belonging to C,
NS and S. This parameter was not affected during infection experiment with any virus.
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NS. Ferrets with mild clinical score showed a tendency of
decreased on body weight (p < 0.10) when compared with
control group at 4 dpi (Figure 1B). Body temperature was
not affected by infection with any virus, although some
increase of temperature was observed in ferrets belonging
to the S group at day 1 pi which returned to control levelsby day 5 pi. Any change in temperature was statistically
significant (Figure 1C).
Histopathology and Immunohistochemistry
Most significant lesions were observed in lungs from in-
fected animals. Interstitial pneumonia, also called diffuse
alveolar damage (Figure 2C), characterized by an acute
Figure 2 Lung histopathology and NP inmunohistochemestry of ferrets with different clinical symptoms. (A) Histopathology of a
representative control ferret. Hematoxilin/Eosin (HE) stain (20x objective field); (B) Histopathology of a representative ferret which presented NS
signs and bronchopneumonia. Bronchiolar-alveolar junction showing mild lymphoplasmacytic infiltration and bronchial epithelium slough.
HE stain (20x objective field; (C) Histopathology of a representative ferret presenting S signs exhibiting severe clinical signs and interstitial
pneumonia. Detail of the alveolar interstitium showing diffuse alveolar damage with presence of hyaline membranes, edema, large macrophagic
infiltrate and hemorrhage. HE stain (20x objective field); (D) NP staining in a representative control ferret. Haematoxylin counterstain (40x objective
field); (E) NP staining in a representative ferret belonging to the NS group showing viral antigen present only in bronchial epithelia. Haematoxylin
counterstain (40x objective field); (F) NP staining in a representative ferret belonging to the S group, showing viral antigen staining in pneumocytes
and alveolar macrophages. Haematoxylin counterstain (40x objective field).
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phages and hyaline membranes filling the alveolar lumen
was observed in lungs of ferrets presenting severe clin-
ical symptoms (S). Mild bronchopneumonia (Figure 2B)
or bronchitis, consistent with a mild exudative lesion
with suppurative or lymphoplasmacytic infiltration and
bronchial epithelial necrosis was observed in animals which
reported only mild clinical signs (NS). No histological ab-
normalities were found in control ferrets (Figure 2A).
Presence of NP viral antigen detected by immunohis-
tochemistry (IHC) was only observed in animals sacri-
ficed at 4 dpi (Figure 2D-F). Presence of viral antigen
correlated with the grade of pathological lesion observed.
Animals which presented more severe pathological lesions
showed higher amounts of viral antigen by IHC when
compared the lesions and NP staining from animals
belonging to the NS group with their counterparts
from the S group. In the S group animals, viral antigen
was mainly observed in the bronchiolar epithelium, in
the surface and glandular epithelium in the bronchi
and interstitially in the alveolar septa and alveoli,mainly located in the alveolar epithelium. Animals which
presented mild pathological lesions showed a lesser
amount of NP positive cells or did not show any positive
cells at all; in these animals positivity was restricted to
bronchiolar epithelial cells. In summary, animals present-
ing more severe pathological lesions showed higher
amounts of viral antigen mainly observed in the bron-
chiolar and bronchial epithelium, glandular epithelium
in the bronchi and interstitially in the alveolar septa
and alveoli, mainly located in the alveolar epithelium.
Acute phase proteins (APP)
Haptoglobin (Hp) being an APP, may increase in plasma
in any inflammatory process like IV infection. Indeed, an
increase in Hp levels was reported during influenza in
pigs caused by A(H1N1)pdm09 virus [14,15]. In ferrets,
pre-inoculation individual levels of Hp were found to be
below 1.94 mg/ml. The highest individual level after
infection reached 2.44 mg/ml (at 2 dpi) in an animal
presenting mild symptoms of the disease. No signifi-
cant changes in the concentration of Hp were observed
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trations of Hp increased from 0.87 to 2.08 (at 2 dpi)
and from 1.42 to 2.01 (at 4 dpi) in the S and NS, respect-
ively (Figure 3A).
Serum amyloid A (SAA) is another important APP
that has also been reported to increase in serum from
humans and horses after influenza infection [14,15]. In
ferrets, an increase of SAA after infection with the virus
was detected when compared to their control counter-
parts only at 2 dpi. Large variations in SSA concentra-
tions were observed between animals presenting severe
symptoms of the infection at 2 dpi. At this time point,
the highest mean peak level reached 4.1 ng/ml. However,
the SAA concentration had decreased to zero in the
group presenting severe symptoms at day 4 dpi, in the
mild group the concentration had stagnated (Figure 3B).
Antibody response
Sera from 0, 10 and 14 dpi were examined for the pres-
ence of specific antibodies against influenza NP. AllFigure 3 Concentrations of acute phase proteins in serum of influenz
Amyloid (SAA) of two groups of ferrets presenting S and NS symptom
intratracheal infection with A(H1N1)pdm09 viruses.infected animals showed a positive response at 10 and
14 dpi (Table 3). Antibody response to M and F viruses
was determined by hemagglutination inhibition (HAI)
assay in sera from 2, 4, 7, 10 and 14 dpi. Control ferrets
shown to be seronegative at all time-points. Animals
belonging to NS and S revealed an early presence of
hemagglutinin inhibiting antibodies for M and F viruses as
soon as 7 dpi. There was a strong HI antibody response to
both viruses in sera of infected-groups at 10 and 14 dpi
(Table 3). There was not significant differences within
infected-groups. Control group showed statistically signifi-
cant differences with infected groups at all time points.
Viral load
To test the presence of infectious virus particles, samples
of trachea, lung and broncheo alveolar lavage (BAL)
were collected at 4 and 7 dpi. Control animals were
negative. Data of viral titres of trachea, lung and BAL
was analyzed as a set including the three different tissues
(Figure 4). Viral titres were similar at 4 dpi in tracheaa virus infected ferrets (A) Haptoblobine (Hp) and (B) Serum
s of the disease, before and at various time points after
Table 3 Antibody response against F and M was determined by NP ELISA and HIAAt days 10 and 14 serum samples
were collected to determine positive Influenza A samples by NP ELISA
Group Animal
number
Virus ELISA
NP
IHA IHA
A/CastillaLaMancha/RR5911/2009 (F) A/CastillaLaMancha/RR5661/2009 (M)
10dpi 14dpi 2dpi 4dpi 7dpi 10dpi 14dpi 2dpi 2dpi 4dpi 7dpi 10dpi 14dpi
C 1 mock - - <40 <40 <40 <40 <40 <40 <40 <40 <40 <40
2 mock - - <40 <40 <40 <40 <40 <40 <40 <40 <40 <40
NS 3 M + + <160 <160 <10.240 <5.120 <10.240 <80 <40 <5.120 <10.240 <20.480
10 F + + <320 <320 <10.240 <10.240 <10.240 <80 <160 <10.240 <20.480 <20.480
11 F + + <320 <320 <5.120 <10.240 <5.120 <160 <160 <5.120 <20.480 <5.120
S 4 M † † <160 <320 † <80 <160 †
5 M + + <320 <320 <10.240 <10.240 <10.240 <80 <160 <10.240 <10.240 <10.280
9 F † † <320 † <80 †
Antibody response against F and M virus was determined by HIA analyzing serum samples from 2, 4, 7, 10 and 14 dpi. † Animals were sacrificed following the
protocol described in material and methods.
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were compared. On the contrary, ferrets with severe
clinical signs at 4 dpi exhibited higher viral titres than
their counterparts in the NS group in the lungs and BAL.
This difference was statistically significant (p = 0.01). No
virus was detected in trachea, lung or BAL at 7dpi.
Discussion
On April of 2009, a new type of influenza H1N1 came
to the world's attention due to their characteristics of
rapid spread among humans all over the world. Patients
affected by A(H1N1)pdm09 infection developed a whole
range of clinical features. Most patients infected by the
virus experienced uncomplicated illness, however, a small
subset of patients developed a severe disease which may
be related to their individual susceptibilities. Influenza
pandemic viruses used for the infection in our study were
collected from two young adults patients with unknown
previous comorbid conditions as asthma, pregnancy,
diabetes or obesity, which were reported to be highly
associated with the development of critical illness in
H1N1pdm infected patients [16-19]. Also, other inves-
tigations attempt to study specific markers associated
to severity during H1N1pdm infection in order to described
unknown underlying immunosupressory conditions [20].
Ferrets were selected to mimic the variability within a het-
erogeneous population. Our study underlined that ferrets
are an appropriate animal model to study the individual
clinical characteristics observed on humans infected with
the A(H1N1)pdm09 virus. Ferrets were infected with two
strains of A(H1N1)pdm09 2009 virus, one isolated from a
patient exhibiting mild clinical signs of infection, and the
other one from a patient with a fatal outcome. Genetic
characterization of both virus was already discussed else-
where [9]. There were eleven males and three females with
ages ranging from one to two years of adult life. Surprisingly,
during the course of the experiment, ferrets from bothinfected groups, showed a clinical score severity that
was independent from the virus used for infection. An-
imals infected with M virus presented mild to severe
clinical signs and one ferret presented a critical condi-
tion and was euthanized for humanitarian reasons. The
same picture was observed in the F-infected group.
Control ferrets scored up to 4 points that were attrib-
uted to the mock treatment. These findings differ from
the results obtained in a previous work in which the
same two IV strains were used to infect mice. The data
in the murine model indicated that F virus was more
pathogenic, shown by the morbidity and mortality
rates observed in the F-infected mice [9]. However, in
the present work, due to the clinical observations reg-
istered during the ferret infection, the data were ana-
lysed dividing all animals by the clinical score. In such
manner, each animal was treated by their individual
clinical condition observed during infection. Changes
on weight, body temperature and activity are the most
common parameters observed following infection used
to evaluate the clinical profiles associated with influenza
infection in ferrets. For example, the activity scoring, gen-
erally used to assess activity changes in infected ferrets are
based on the scoring system described by Reuman et al.
[21] and Zitzow et al. [22]. In order to perform a more
comprehensive evaluation, extensive data were recorded
including a whole range of clinical signs (Table 1). The re-
sults in this work showed that the clinically severe animals
showed a pattern of clinical signs similar to that com-
monly founded on ferrets infected with a HPAI, whereas
the animals presenting mild clinical signs response exhib-
ited similar symptoms to those infected with a seasonal
virus [23] (Figure 1A).
Ferrets belonging to the NS group presented mild
histological lesion generally characterized by mild bron-
chopneumonia or bronchitis. On the contrary, the lung
pathology observed in animals belonging to the S group
Figure 4 Viral replication in trachea, lungs and broncheo
alveolar lavage (BAL) of infected ferrets. At 4 and 7 dpi,
samples of trachea, lung and BAL were collected to measure viral
titers. (A) Virus titers in trachea; (B) Lung titers, (C) Viral titers in BAL.
Martínez-Orellana et al. Virology Journal  (2015) 12:48 Page 9 of 10showed signs of acute inflammation as diffuse alveolar
damage, similar to the histological lesions presented on
deceased human patients infected with the A(H1N1)
pdm09 [24].Recent studies performed in pigs showed interesting
data on the immune responses, reflected on serum con-
centrations of acute phase protein as C-reactive protein,
haptoglobin and serum amyloid A in response to IV
[14,15]. In these studies, positive correlations were found
between serum concentration of Hp and SAA and lung
scores, and between clinical score and concentrations of
SAA in IV infected pigs [14]. The results in this work
are the first study in which Hp and SAA have been ana-
lysed in the context of IV in ferrets, providing further in-
formation of the acute phase proteins on the immune
response to influenza infection. Our study suggested
that there was an increase of Hp and SAA at day 2 pi
(Figure 3A and B), however no statistical differences
were found, probably due to the low number of animals
per group. These results pave the way for analysing further
APP responses to influenza infection in ferrets that could
be useful for the ferret daily clinical practice.
In relationship to the antibody response, animals showed
seroconversion from 10 dpi by ELISA and HIA in both in-
fected groups. Interestingly, cross-reactive antibodies were
generated, indicating that similar regions of each HA mol-
ecule was recognized by the immune system in ferrets.
Noteworthy, HA sequence has only three changes at
the aminoacid level when comparing M and F virus
[9]. Interestingly, it has been reported that either single
or double point mutations may alter epitopes of a par-
ticular antigenic site in the 2009 H1N1 pandemic virus
HA [25].
Viral replication in the respiratory tract of the infected
ferrets was directly associated to the more severe path-
ology observed. As expected, animals on S group showed
higher viral titre (Figure 4) and higher tissue damage
(Figure 2) which can be associated to the individual
animal condition, but not to differential virulence in
each strain, as it was the case in mice experiments [9].
Finally, it has been shown that detrimental innate cellular
responses have been linked to up-regulation of several pro-
inflammatory cytokines and chemokines and the down-
regulation of IFNα in the lungs in ferrets infected with this
two A(H1N1)pdm09 virus. Additionally, severe lung
lesions were associated with greater up-regulations of
pro-apoptotic markers and higher levels of apoptotic
neutrophils and macrophages [26].
Our results suggested that the severity in the progress of
infection was independent from the virus used for infection,
which might be associated to the host immune response.
Also, clinicopathological outcomes of A(H1N1)pdm09
infection in ferrets were not only due to viral replica-
tion abilities but also depended on the hosts’ capacities
to mount efficient immune responses to control viral infec-
tion of the lung. Finally, ferret diversity in responding to A
(H1N1)pdm09 may mimic the variability observed in the
human population.
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